Dasatinib (Australia) – Patient-Friendly Medicine Information

Dasatinib is an oral medicine used to treat certain types of cancer, particularly cancers driven by abnormal signals inside cells. This guide explains how dasatinib works, how it is used in everyday life, and the important safety and interaction considerations for people in Australia.

Please note: every person’s situation is different. Your prescriber and pharmacist will tailor the plan for you. Always follow the instructions provided with your medicine.

Basic product information

How dasatinib works (mechanism of action)

Dasatinib belongs to a group of medicines called tyrosine kinase inhibitors. These medicines block specific proteins (kinases) that help cancer cells grow and survive.

A key target is BCR-ABL, a fusion protein found in some forms of leukaemia (notably chronic myeloid leukaemia and certain Philadelphia chromosome–positive leukaemias). By inhibiting BCR-ABL and related signalling pathways, dasatinib can:

• reduce uncontrolled cell growth
• promote cancer cells to die or stop dividing
• help the body achieve and maintain disease control

What it is used for (indications)

In Australia, dasatinib is used for specific blood cancers where the cancer’s growth depends on BCR-ABL and related kinases. Typical uses include:

• Chronic myeloid leukaemia (CML) – commonly for people who are newly diagnosed or who have disease that is resistant or not responding to prior treatment.
• Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL) – in adults (and sometimes based on local protocols/age groups), particularly when the disease is resistant or not responding to previous therapy.
• Other specific circumstances – depending on the person’s cancer characteristics, previous medicines, and specialist assessment.

Your oncology team will confirm the exact diagnosis and treatment goal for your situation.

Typical dosing approach and timing

Dasatinib dosing is individualised based on the cancer type, disease phase, and how you respond to treatment. It is important to use the dosing schedule provided for you.

General timing points for daily dosing:

• Take it at about the same time each day to maintain consistent drug levels.
• If you miss a dose, follow your clinician’s instructions or the medicine instructions supplied by the pharmacy. In general, many oral targeted medicines are not “doubled up” after missed doses without specific guidance.
• Do not stop or change your dose without medical advice, even if you feel well or if side effects occur.

Missed doses: Because dosing schedules differ by condition and treatment plan, the correct approach can vary. If you have missed a dose, contact your oncology team or pharmacist for advice.

How to take dasatinib (practical use tips)

• Swallow tablets whole with water. If your prescribed form requires a specific preparation method, only use the method given by your pharmacist or specialist.
• Regular hydration and good oral hygiene can help manage treatment-related side effects such as mouth irritation.
• Avoid handling risks: Keep tablets in their original packaging and store safely away from children. If tablets are visibly damaged, do not use them; ask your pharmacist.
• Keep a medication diary (time taken, side effects, other medicines used). This can help your healthcare team adjust safely.
• Attend blood tests and monitoring visits as scheduled. Dose adjustments are often guided by test results and symptoms.

Food interactions: what to know

Dasatinib can interact with food and changes in stomach conditions. Food may affect how much of the medicine your body absorbs. To help maintain consistent effect:

• Follow the meal advice provided with your medicine. Your pharmacist may recommend taking it with or without food based on your product information.
• If you experience stomach upset, do not self-adjust without advice—your clinician may have specific guidance.
• Antacids and acid-reducing medicines: medicines that affect stomach acid (such as some antacids) can alter absorption. If you need reflux or indigestion treatment, speak to your pharmacist for an appropriate option and timing.

Important: Always check whether your specific product instructions advise taking dasatinib with food or on an empty stomach. Different cancer medicines may have different requirements.

Alcohol interactions

Alcohol is not always strictly contraindicated with dasatinib, but combining alcohol with cancer treatment can increase risks such as:

• tiredness, dizziness, or nausea
• liver stress (dasatinib can affect liver function in some people)
• higher chance of dehydration if you feel unwell

Practical approach: If you drink alcohol, discuss a safe amount with your oncology team. Avoid binge drinking and do not drink if you feel unwell or if your liver tests are abnormal.

Medicine interactions (including common categories)

Dasatinib’s levels can be affected by other medicines, especially those that change liver enzymes and drug transporters. Tell your pharmacist about all medicines and supplements you use, including:

• prescription medicines
• over-the-counter products
• vitamins, herbal products and “natural” supplements

Key interaction categories to discuss

• Acid-reducing medicines (antacids, H2 blockers, proton pump inhibitors). These may interfere with absorption. Your pharmacist can suggest timing or alternatives.
• Strong enzyme inducers or inhibitors. Some medicines can significantly raise or lower dasatinib levels, affecting safety and effectiveness.
• Other medicines that affect heart rhythm (QT prolongation) or heart function. Dasatinib may be associated with heart-related effects in some people.
• Medicines that affect bleeding risk. If you are on anticoagulants/antiplatelets, your healthcare team will balance bleeding and clotting risks.
• Herbal supplements, especially St John’s wort, which may strongly reduce medicine levels.

If you are unsure whether something interacts, ask before taking it. A brief check by your pharmacist can prevent problems.

Pharmacokinetics (how the body handles the medicine)

Pharmacokinetics describes how the medicine is absorbed, distributed, metabolised and eliminated. While individual results vary, the general characteristics of dasatinib include:

• Absorption: dasatinib is absorbed after oral dosing. Food can influence absorption, which is why meal instructions matter.
• Distribution: the medicine distributes into body tissues; protein binding plays a role in how much active medicine is available.
• Metabolism: dasatinib is primarily metabolised in the liver by enzyme pathways. Liver function can therefore influence exposure.
• Elimination: drug metabolites are cleared mainly through hepatic processes. Some excretion occurs through bile/faeces.
• Steady state: with daily dosing, drug levels typically reach a steady pattern after several doses, and effects/side effects are assessed over time.

Your clinicians monitor safety with blood tests and symptom review because metabolism and tolerance can vary among individuals.

Safety profile: common and serious side effects

Like all medicines, dasatinib can cause side effects. Many people experience mild to moderate effects that are manageable, while others may experience more serious complications. It is important to know what to watch for and to seek advice quickly when needed.

Common side effects

• Nausea and/or reduced appetite
• Diarrhoea or constipation
• Fatigue, weakness or low energy
• Headache
• Skin rash or dry skin
• Muscle or joint aches
• Mild swelling (fluid retention can occur)
• Low blood counts (anaemia, reduced white cells, or reduced platelets) which can increase infection or bleeding risk

Important serious risks to discuss

• Pleural effusion (fluid around the lungs): symptoms may include shortness of breath, chest pain, persistent cough or feeling breathless when resting.
• Fluid retention / oedema: swelling in feet/legs or sudden weight gain.
• Infection risk due to lowered white cells: fever, chills, sore throat, or signs of infection require prompt medical attention.
• Bleeding risk due to low platelets: unusual bruising, nosebleeds, bleeding gums, black/tarry stools or blood in urine require urgent assessment.
• Liver function changes: yellowing of eyes/skin, dark urine, severe fatigue, or upper right abdominal discomfort.
• Heart-related effects in some people: palpitations, dizziness, fainting, or chest discomfort should be assessed promptly.
• Severe allergic reactions (rare): swelling of face/lips, difficulty breathing, hives.

If you develop concerning symptoms, contact your healthcare team urgently. In Australia, if symptoms are severe or life-threatening, call 000 or attend the nearest emergency department.

Monitoring while taking dasatinib

Monitoring helps detect side effects early and supports safe treatment. Your healthcare team may schedule:

• Regular blood tests to check blood counts (anaemia, neutropenia, platelets)
• Blood chemistry and liver function tests
• Assessment of symptoms such as breathlessness, swelling, bruising, infections, and fatigue
• Heart monitoring if you have cardiovascular risk factors or if your clinician requests it

Adjustments and dose changes

If side effects occur, your healthcare team may recommend changes such as supportive medicines, dose delays, or dose adjustments. These decisions are based on:

• the severity of symptoms
• blood test results
• overall cancer response
• other medicines you are taking

Never adjust your dose on your own. Ask your prescriber or pharmacist if you’re unsure.

Practical tips for day-to-day comfort

• For nausea: small, frequent meals and avoiding strong odours may help. Ask your pharmacist about anti-nausea options if symptoms are persistent.
• For diarrhoea: maintain hydration and consider oral rehydration solutions. Report persistent diarrhoea promptly.
• For fatigue: pace activities and prioritise rest. Tell your team if fatigue is worsening.
• For mouth discomfort: use gentle mouth care (soft brush, bland rinses). Seek advice for sores or pain.
• For infection prevention: practice good hygiene and report fever quickly.
• For bleeding prevention: avoid unnecessary injury, use a soft toothbrush, and be cautious with sharp tools.

Alternative options (discuss with your specialist)

Treatment for BCR-ABL–positive blood cancers may involve different targeted medicines and strategies depending on prior response, cancer phase, tolerance, and drug interactions. Alternatives may include other tyrosine kinase inhibitors (TKIs), such as:

• Imatinib
• Nilotinib
• Bosutinib
• Ponatinib (for selected situations)
• Other specialist regimens or supportive approaches depending on diagnosis and disease stage

Which option is best depends on factors like previous therapy, side effect profile, heart and lung health, liver function, and drug availability. Your oncology team can explain the most appropriate alternatives for your situation.

Market and legal context for Australia

In Australia, cancer medicines are regulated by the Therapeutic Goods Administration (TGA) and are supplied through authorised channels. Funding and access may involve the Pharmaceutical Benefits Scheme (PBS) where applicable, along with hospital supply arrangements and specialist prescribing pathways.

Availability of specific strengths and brands can vary by supply chain. Your pharmacy can provide up-to-date information about:

• stock availability
• estimated delivery times
• substitution options if different brands are supplied
• how your medicine is funded in your care plan

Recent guidance and ongoing safety updates

Safety information for cancer medicines can evolve over time as new clinical data and real-world safety reports are reviewed. In Australia, healthcare professionals rely on:

• TGA-approved product information
• updates from medicine regulators and professional bodies
• hospital and oncology clinic protocols

For the latest safety and monitoring guidance relevant to your product and dose, consult your oncology team or pharmacist. If you notice any unusual or worsening symptoms, report them promptly—early assessment is important with medicines that can affect lungs, blood counts, liver function and heart health.

Delivery, ordering and availability

Online pharmacy services in Australia typically provide:

• Secure packaging to protect tablets and maintain safe handling
• Tracking and estimated delivery windows (depending on service level)
• options for standard or express delivery where available
• pharmacist support to confirm product details and interaction checks

Availability may depend on your location and current stock levels. If an item is temporarily unavailable, your pharmacy may contact you with alternatives or resupply estimates. Always ensure that you receive the correct strength and brand listed in your treatment plan.

FAQ

1) How long does it take dasatinib to work?

Some people begin to see early responses in weeks, while deeper responses may take longer. Your oncology team will monitor response using blood tests and other assessments over time.

2) Can I take dasatinib with food?

Dasatinib absorption may be affected by food. Follow the specific meal instructions provided for your product and dose. If you have reflux or you use antacids/acid reducers, ask your pharmacist for timing guidance.

3) What should I do if I miss a dose?

The correct action depends on your dosing schedule and timing. Contact your pharmacist or oncology team for advice rather than guessing.

4) What blood tests will I need?

Many patients have regular tests for blood counts and liver function. The frequency depends on your stage of treatment, previous results, and any symptoms you develop.

5) How will I know if I have pleural effusion or fluid around my lungs?

Watch for shortness of breath, chest discomfort, persistent cough, or breathlessness that worsens. If these occur, seek medical assessment promptly.

6) Are there foods I should avoid?

Specific foods may affect absorption indirectly if they influence stomach conditions. The most important guidance is usually the exact meal timing and avoiding unsupervised use of acid-reducing medicines without advice.

7) Can I take herbal supplements?

Herbal products can interact with cancer medicines. Speak with your pharmacist before starting any supplement. Avoid St John’s wort unless your clinician confirms it is safe.

8) Can I drive while taking dasatinib?

Dasatinib can cause fatigue, dizziness or other effects in some people. If you feel unwell, avoid driving and speak to your healthcare team about side effects.

9) Who should I contact for side effects?

Your oncology clinic or pharmacist is the best first contact for advice on symptoms and medication adjustments. For severe symptoms (such as difficulty breathing, fainting, uncontrolled bleeding or signs of serious allergic reaction), seek urgent medical care immediately.

10) Is there any contraception guidance?

Many cancer medicines can affect pregnancy outcomes. Discuss contraception and family planning with your healthcare team before starting treatment. Your clinicians can provide guidance tailored to your circumstances.

Key takeaways

• Dasatinib is a targeted kinase inhibitor that blocks cancer-signalling proteins such as BCR-ABL.
• It requires careful monitoring for blood counts, liver function, and lung/heart-related symptoms.
• Food and acid-reducing medicines can affect absorption, so follow product-specific instructions.
• Tell your pharmacist about all medicines and supplements to prevent interactions.
• Seek urgent advice for symptoms such as shortness of breath, significant swelling, fever, unusual bleeding, or signs of liver problems.

If you would like, tell us which dasatinib strength and formulation you have (and any reflux medicines or other drugs you take), and we can help you understand common interaction considerations to discuss with your pharmacist.